Oncotarget Combined Approach Improves Anti-tumor Antibody Therapy in Melanoma Researchers from Columbia University demonstrate that, in mouse-modeled melanoma, the therapeutic efficacy of unmodified anti-tumor... read more January 19, 2021
Oncotarget Can MEK Inhibitor Drugs Improve COVID-19? A promising new treatment option for the coronavirus was studied using a COVID-19 pseudovirus approach... read more November 17, 2020
Oncotarget Trending with Impact: Basal Cell Bladder Cancer and MEK Inhibitors For patients with basal cell bladder cancer, researchers in this study identify MEK inhibitors as... read more November 12, 2020